FDA Could Approve COVID-19 Vaccine This Fall
June 25, 2020
By Neozene

This article originally appeared in FiercePharma and was written by Eric Sagonowsky About six months into the pandemic and about 130 days until the U.S. presidential election, COVID-19 vaccines are moving ahead at record speeds. Now, a group of analysts predicts “at least one” vaccine will be approved before November 3. Jefferies healthcare strategist Jared Holz told MarketWatch that “perhaps multiple vaccines” could get FDA authorizations “early in the fourth quarter and quell fears of a second wave of COVID-19.” The team cited several reasons why an approval, or emergency use

Read More

The United Kingdom Approves Dexamethasone in COVID-19 Treatment
June 17, 2020
By Neozene

The following article originally appeared on FiercePharma and was written by Eric Sagonowsky Right on the heels of data showing the decades-old, inexpensive steroid dexamethasone can reduce COVID-19 deaths among hospitalized patients requiring oxygen, the U.K. government granted a world-first approval. The nod, in COVID-19 patients who are hospitalized and requiring oxygen, including those on ventilators, came hours after government-funded research proved the drug reduced risk of death by 35% for patients on ventilators and 20% for those receiving oxygen. The medicine reduced 28-day mortality by 17% in the large

Read More

Experts Question Why Some Drugmakers Were Left Off ” Operation Warp Speed”
June 9, 2020
By Neozene

This article originally appeared in FiercePharma and was written by Eric Sagonowsky  All eyes are on a handful of drug companies after news that the U.S. is prioritizing five COVID-19 vaccine programs. But since the selections went public, experts have been raising questions about the process and the drugmakers that were left off. Earlier this week, The New York Times reported that AstraZeneca, Pfizer, Merck, Johnson & Johnson and Moderna had scored “finalist” status at Operation Warp Speed, an aggressive program to deliver COVID-19 vaccines to Americans this year. Four of

Read More